Skip to content

Clinical trials

Observational Insulinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulinoma Phase: Observational Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20101
20181
20191
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
British Columbia Cancer Agency1
Herlev Hospital1
National Cancer Institute (NCI)1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Sahlgrenska University Hospital1
Sichuan Provincial People's Hospital1
Tianjin Medical University1
University Hospital, Basel, Switzerland1
Vishnevsky Center of Surgery1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulinoma9
Gastrinoma2
Glucagonoma2
Hypoglycemia2
Neoplasms2
Vipoma2
Adenoma, Islet Cell1
Carcinoid Tumor1
Carcinoma, Medullary1
Carcinoma, Merkel Cell1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.